LVS vs MRNA · P/E 28, rev $6.74B vs rev $145.0M
Las Vegas Sands Corp (LVS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
LVS currently screens at market cap $35.70B and trailing P/E 28.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the LVS and MRNA stock pages for the full models.
Not investment advice.